The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people
Open accessAbstract
Purpose Benzodiazepines are effective medicines for insomnia and anxiety but are commonly used beyond recommended treatment time frames, which may lead to adverse drug events. The aim of this systematic review was to critically evaluate the success of interventions used to reduce benzodiazepines and 'Z-drug' use, and the impact of these interventions on clinical outcomes in older adults. Methods A search was conducted in PubMed, Embase, Informit, International Pharmaceutical Abstracts, Scopus, PsychINFO, Cochrane Central Register of Controlled Trials (CENTRAL) and CINAHL. Studies conducted in older adults (≥65 years) and published between January 1995 and July 2015 were included. Two authors independently reviewed all articles for eligibility and extracted the data. Results Seven studies of benzodiazepines and Z-drug withdrawal were identified. Benzodiazepine discontinuation rates were 64.3% in one study that employed pharmacological substitution with melatonin and 65.0% in a study that employed general practitioner-targeted intervention. Mixed interventions including patient education and tapering (n = 2), pharmacological substitution with psychological support (n = 1) and tapering with psychological support (n = 1) yielded discontinuation rates between 27.0 and 80.0%. Five studies measured clinical outcomes following benzodiazepine discontinuation. Most (n = 4) observed no difference in prevalence of withdrawal symptoms or sleep quality, while one study reported decline in…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the elderly, long-term use of BZDs increases the risk of falls and hip fractures, road accidents, cognitive decline, and mortality [32,33,34].”
From Cognitive behavioral therapy and acceptance and commitment therapy for the discontinuation of long-term benzodiazepine use in insomnia and anxiety disorders (2021) · cites this paper as [32]
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010) · International Journal of Surgery · doi:10.1016/j.ijsu.2010.02.007 · Cited by 12,156
Reeve, E., Gnjidic, D., Long, J., & Hilmer, S. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12732 · Cited by 855
Self-citationBenzodiazepine Use in the United States
Olfson, M., King, M., & Schoenbaum, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1763 · Cited by 786
Tannenbaum, C., Martin, P., Tamblyn, R., Benedetti, A., & Ahmed, S. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.949 · Cited by 665
Benzodiazepines revisited—will we ever learn?
Lader, M. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03563.x · Cited by 573
Benzodiazepine use and risk of Alzheimer's disease: case-control study
Billioti de Gage, S., Moride, Y., Ducruet, T., Kurth, T., Verdoux, H., Tournier, M., Pariente, A., & Begaud, B. (2014) · BMJ · doi:10.1136/bmj.g5205 · Cited by 558
Benzodiazepines and Risk of Hip Fractures in Older People: A Review of the Evidence
Cumming, R. G., & Le Couteur, D. G. (2003) · CNS Drugs · doi:10.2165/00023210-200317110-00004 · Cited by 332
Cited by
Polypharmacy Management in Older Patients
Hoel, R. W., Giddings Connolly, R. M., & Takahashi, P. Y. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.06.012 · Cited by 196
Sawan, M. J., Reeve, E., Turner, J. P., Todd, A., Steinman, M. A., Petrović, M., & Gnjidic, D. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1730812 · Cited by 131
Self-citationNg, B. J., Le Couteur, D. G., & Hilmer, S. N. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0544-4 · Cited by 118
Reeve, E., Moriarty, F., Nahas, R., Turner, J. P., O’Donnell, L. K., & Hilmer, S. N. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1397625 · Cited by 97
“Systematic reviews have described the ability to withdraw benzodiazepine use in approximately 25– 85% of older adult users without return of condition (often with tapering regimens to minimize ADWEs) [39,42].”
BackgroundSelf-citationNguyen, V. V., George, T., & Brewster, G. S. (2019) · Current Geriatrics Reports · doi:10.1007/s13670-019-00300-x · Cited by 89
Metadata
- Authors
- Reeve, E., Ong, M., Wu, A., Jansen, J., Petrovic, M., & Gnjidic, D.
- Affiliations
- The University of Sydney (AU)
- Corresponding author
- Reeve, Emily
- Venue
- European Journal of Clinical Pharmacology
- Published
- 2017-04-30
- Volume
- 73
- Issue
- 8
- Pages
- 927-935
- ISSN
- 0031-6970 (ISSN-L)
- 1432-1041
- OpenAlex
- W2610021354
- Cited by
- 192
- References
- 45
- Citations by year
- 2026: 16 · 2025: 26 · 2024: 25 · 2023: 25 · 2022: 19 · 2021: 24 · 2020: 17 · 2019: 20 · 2018: 17 · 2017: 3
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- Locations
- European Journal of Clinical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- benzodiazepine deprescribing, Z-drugs, hypnotics, older adults, benzodiazepine withdrawal, benzodiazepine tapering, patient education, sleep quality, quality of life, adverse drug reactions
- MeSH terms
- Deprescriptions, Aged, Benzodiazepines, Humans, Hypnotics and Sedatives, Sleep Initiation and Maintenance Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people. https://app.cochat.ai/papers/10.1007/s00228-017-2257-8
- The paper
- Reeve, E., Ong, M., Wu, A., Jansen, J., Petrovic, M., & Gnjidic, D. (2017). A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-017-2257-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.